Literature DB >> 21484116

Is interleukin-8 an additional to histopathological changes diagnostic marker in HCV-infected patients with cryoglobulinemia?

Joanna Cielecka-Kuszyk1, Joanna Siennicka1, Joanna Jabłońska2, Olga Rek1, Paulina Godzik1, Daniel Rabczenko3, Kazimierz Madaliński4.   

Abstract

PURPOSE: The aim of this study was to analyze histopathological changes in the liver and serum inflammatory cytokine level in hepatitis C virus (HCV)-infected patients with and without cryoglobulinemia.
METHODS: The study group consisted of 34 patients with chronic hepatitis C, confirmed by serological and virological markers. Ten out of 34 patients had cryoglobulinemia. The control group consisted of 21 healthy persons. Liver biopsy specimens of HCV-infected patients were evaluated by light microscopy using the grade and the stage according to Batts and Ludwig classification. The quantitative measurements of IL-1β, IL-6, IL-8, IL-10, IL-12p70, and tumor necrosis factor in sera were performed by flow cytometry.
RESULTS: The mean age of HCV-infected patients with cryoglobulinemia was higher than age of HCV-infected patients without cryoglobulinemia. Microscopic examination of liver biopsy specimens revealed necroinflammatory activity slightly more prominent in patients with cryoglobulinemia. The most prominent inflammatory changes connected with abundant lymphoid aggregates in most of the examined portal tracts and piecemeal necroses were diagnosed in patients with several extrahepatic manifestations, such as cutaneous manifestations, nephrotic syndrome, polyneuropathy, and arthropathy. Liver fibrosis was similar in patients with and without cryoglobulinemia.
CONCLUSIONS: The serum levels of all proinflammatory cytokines, especially IL-8, were significantly higher in the patients with cryoglobulinemia in comparison with the patients without cryoglobulinemia and healthy persons. All microscopic features did not correlate with the level of any investigated proinflammatory cytokines.

Entities:  

Keywords:  Cryoglobulinemia; HCV infection; IL-8; Liver biopsy; Serum cytokine level

Year:  2011        PMID: 21484116     DOI: 10.1007/s12072-011-9268-9

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  26 in total

1.  High levels of soluble tumor necrosis factor superfamily receptors in patients with hepatitis C virus infection and lymphoproliferative disorders.

Authors:  S Realdon; P Pontisso; F Adami; L Trentin; F Noventa; A Ferrari; I Migliorato; A Gatta; A Alberti
Journal:  J Hepatol       Date:  2001-05       Impact factor: 25.083

Review 2.  Review of cytokine profiles in patients with hepatitis.

Authors:  Qiao-Ling Sun; Wei Ran
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

Review 3.  Enhanced TH1 cytokine production in hepatitis C virus-infected patients with mixed cryoglobulinemia: understanding the pathological issues.

Authors:  Anna Linda Zignego
Journal:  J Hepatol       Date:  2004-12       Impact factor: 25.083

4.  The levels of IL-1beta, IL-4 and IL-6 in the serum and the liver tissue of chronic HCV-infected patients.

Authors:  T W Lapiński
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2001       Impact factor: 4.291

5.  Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis.

Authors:  Zeid Kayali; Victor E Buckwold; Bridget Zimmerman; Warren N Schmidt
Journal:  Hepatology       Date:  2002-10       Impact factor: 17.425

Review 6.  Understanding hepatitis C.

Authors:  John G McHutchison
Journal:  Am J Manag Care       Date:  2004-03       Impact factor: 2.229

Review 7.  The hepatitis C virus enigma.

Authors:  Helge Myrmel; Elling Ulvestad; Birgitta Asjø
Journal:  APMIS       Date:  2009-05       Impact factor: 3.205

Review 8.  Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence.

Authors:  Barbara Rehermann
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

9.  Short-term changes of serum IL-2 and IL-6 induced by interferon alpha-2b in patients with chronic hepatitis C.

Authors:  W Mazur; U Mazurek; M Jurzak; T Wilczok; M Gonciarz; Z Gonciarz
Journal:  Med Sci Monit       Date:  2001-05

10.  Association of serum interleukin-8 with virologic response to antiviral therapy in patients with chronic hepatitis C.

Authors:  Ulrike Mihm; Eva Herrmann; Ulrike Sarrazin; Michael von Wagner; Bernd Kronenberger; Stefan Zeuzem; Christoph Sarrazin
Journal:  J Hepatol       Date:  2004-05       Impact factor: 25.083

View more
  1 in total

Review 1.  Inflammatory and cardiovascular diseases biomarkers in chronic hepatitis C virus infection: A review.

Authors:  Ahmed Babiker; Mohamed Hassan; Safwan Muhammed; Gregory Taylor; Bhawna Poonia; Anoop Shah; Shashwatee Bagchi
Journal:  Clin Cardiol       Date:  2019-11-30       Impact factor: 2.882

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.